Sudden Death Clinical Trial
— SUIVIPROCHEOfficial title:
Sudden Death Counselling and Its Impact on Family Members of Sudden Death Victims
Verified date | April 2024 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Assessment of the psychological benefit of the proposition by prehospital medical team of a sudden death counselling on family members of sudden death victims.
Status | Completed |
Enrollment | 624 |
Est. completion date | March 25, 2024 |
Est. primary completion date | November 13, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: A first-degree relative of a: - patient aged 18-75 years - with an out-of-hospital sudden death* - and cardiopulmonary resuscitation attempted Relative aged = 18 years Given consent for the study. Sudden death definition*: An unexpected cardiac arrest without obvious extracardiac cause, leading to a collapse in front of a witness (or in the absence of witnesses, occurring within the hour after the onset of symptoms). Exclusion Criteria: Relative under guardianship/curatorship Relative unable to communicate Relative not affiliated to a medical insurance |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Necker-Enfants malades | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris | INSERM U970 |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hospital Anxiety and Depression Scale, sub-section Depression (HADSD) >10 | Percentage of relatives with moderate to severe symptoms of depression evaluated by the 'Hospital Anxiety and Depression Scale' score, subscale Depression (HADSD) >10 | at 3 months from the sudden death | |
Primary | Hospital Anxiety and Depression Scale, sub-section Anxiety (HADSA) >10 | Percentage of relatives with moderate to severe symptoms of anxiety evaluated by the 'Hospital Anxiety and Depression Scale' score, subscale Anxiety (HADSA) >10 | At 3 months from the sudden death | |
Secondary | Impact of Event Scale-revised score (IES-R) = 33 | Percentage of relatives with symptoms of post-traumatic stress disorder evaluated by the 'Impact of Event Scale' score (IES-R) = 33 | at 3 months from the sudden death | |
Secondary | Medical Outcome Study Short Form Health Survey (SF-12) | Quality of life questionnaire : the SF-12 is the 12 item abbreviated form of SF-36 survey. It provides information about how participants feel, and how well they have been able to perform their usual activities. SF-12 questions make up 8 scales: Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, Mental Health . Transformed physical component summary score (PCS) and transformed mental component summary score (MCS) are derived using the sum of all 12 items and scored onto a 0-100 scale such that a higher score indicates a better health state and better functioning. | At 3 months from the sudden death | |
Secondary | Visits number to the general physician | At 3 months from the sudden death | ||
Secondary | Drug use | At 3 months from the sudden death | ||
Secondary | Visits number to the psychologist and/or psychiatrist | At 3 months from the sudden death | ||
Secondary | Relatives number integrating a grief recovery support group | Number of participants that have integrated a grief recovery support group | At 3 months from the sudden death | |
Secondary | Feeling of the sudden death consultation or not by the relatives | At 3 months from the sudden death | ||
Secondary | Proportion of identified causes of sudden death | At 3 months from the sudden death | ||
Secondary | Proportion of familial screening | At 3 months from the sudden death |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02180854 -
Correlation Between Monitoring Frequency and Clinical Deterioration in Hospitalized Patients
|
N/A | |
Active, not recruiting |
NCT01185756 -
MIBG Scintigraphy as a Tool for Selecting Patients Requiring Implantable Cardioverter Defibrillator (ICD)
|
N/A | |
Active, not recruiting |
NCT02933437 -
The Response To Ajmaline Provocation in Healthy Subjects
|
Phase 2 | |
Recruiting |
NCT02920203 -
Genetic Autopsy and Sudden Death
|
N/A | |
Recruiting |
NCT02816047 -
Austrian Wearable Cardioverter Defibrillator Registry
|
||
Completed |
NCT04918303 -
Skin Sympathetic Nerve Activity and Cardiac Arrhythmia
|
N/A | |
Recruiting |
NCT00469794 -
The Significance of Arrhythmias in Athletes
|
N/A | |
Completed |
NCT00692666 -
Letigen® and Cardiovascular Morbidity
|
Phase 4 | |
Completed |
NCT02527031 -
A Comparative Study Between a Pre-hospital and an In-hospital Circulatory Support Strategy (ECMO) in Refractory Cardiac Arrest (APACAR2)
|
N/A | |
Withdrawn |
NCT01422174 -
Clinical Registry on Sudden Death Primary Prevention at Latin America
|
N/A | |
Recruiting |
NCT00673842 -
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
|
Phase 3 | |
Completed |
NCT01326624 -
Study of the Wearable Defibrillator in Heart-Failure Patients
|
N/A | |
Recruiting |
NCT01847378 -
Feasibility of Contact Force Catheter Mapping and Ablation in Epicardial and Endocardial Ventricular Tachycardias
|
N/A | |
Recruiting |
NCT00741728 -
Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population
|
N/A | |
Completed |
NCT01446965 -
Vest Prevention of Early Sudden Death Trial and VEST Registry
|
N/A | |
Recruiting |
NCT02732067 -
Death Rate in Anesthesia, a Study in a Tertiary Hospital
|
N/A | |
Recruiting |
NCT02685540 -
Death Rate in Anesthesia: A Study in a Tertiary Hospital
|
N/A | |
Completed |
NCT01804439 -
Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes
|
N/A | |
Recruiting |
NCT02874469 -
Impact of an Intensive Care Diary on Post-traumatic Stress Disorder After a Resuscitated Sudden Death
|
N/A | |
Completed |
NCT03111043 -
Head-to-pelvis Computed Tomography Evaluation of Sudden Death Survivors
|